Medpace Holdings Stock Tumbles On Q2 Earnings: What Investors Need To Know - Benzinga
Medpace Holdings, Inc. Common Stock · SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH · Now $451.47
+6.5% in 7d after detection
Post-detection moves
1h
—
1d
+0.5%
3d
+3.1%
7d
+6.5%
30d
—
Get alerts like this in real time
Push notifications the moment a signal fires. No spam, no crypto, no fluff.
Download for iOS